Busulfex and malaise 
Busulfex and malaise Patient Reports February 13, 2012
Busulfex Side Effects Report #5819581-6
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 07, 2008. Female patient, child 9 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, anorexia, bone marrow transplant
, condition aggravated, cystitis haemorrhagic, diarrhoea, malaise, nausea , stomatitis. Busulfex dosage: 11.1 ML, INTRAVENOUS, 14.8 ML DAILY DOSE; INTRAVENOUS, 3.7 ML, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with CYTARABINE, MELPHALAN, ETOPOSIDE, VALPROATE, METHOTREXATE, TACROLIMIS. Patient died.Busulfex Side Effects Report #5803072-2
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on June 23, 2008. Male patient, child 8 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, convulsion, diarrhoea, escherichia infection, febrile neutropenia, graft versus host disease, liver function test abnormal, malaise, stomatitis. Busulfex dosage: 10 ML, INTRAVENOUS. During the same period patient was treated with ANTILYMPHOCYTE IMMUNOGLOBULIN, FLUDARABINE PHOSPHATE, VALPROATE, MIDAZOLAM. Patient was hospitalized. Patient recovered.
Busulfex Side Effects Report #5871281-2
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 19, 2008. Male patient, child 7 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, anorexia, bone marrow transplant
, cystitis haemorrhagic, diarrhoea, malaise, nausea , sepsis , stomatitis. Busulfex dosage: 68 ML INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VALPROATE, LENOGRASTIM, CYCLOSPORINE. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5819493-8
Busulfex side effect was reported by a Health Professional from JAPAN on July 08, 2008. Male patient, 69 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, diarrhoea, graft versus host disease, jaundice cholestatic, malaise, nausea
, stomatitis. Busulfex dosage: 30 ML INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHSOPHATE, VALPROATE, MELPHALAN, FILGRASTIM, TACTROLIMUS. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5743646-0
Busulfex side effect was reported by a Physician from JAPAN on May 08, 2008. Female patient, 67 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute respiratory failure, anorexia, cytomegalovirus viraemia, diarrhoea, enterobacter sepsis, malaise, nausea
, renal failure acute, thrombocytopenia. Busulfex dosage: 24 ML. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, NEUPOGEN, METHOTREXATE, TACROLIMUS. Patient died.Busulfex Side Effects Report #5811841-8
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 01, 2008. Male patient, 67 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, malaise, staphylococcal sepsis. Busulfex dosage: 32 ML, DAILY DOSE INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, LENOGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient recovered.
Busulfex Side Effects Report #5819440-9
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 08, 2008. Male patient, 67 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, chest discomfort, constipation
, convulsion, diarrhoea, encephalitis , erythema, malaise, oedema. Busulfex dosage: 30 ML, INTRAVENOUS. During the same period patient was treated with MELPHALAN, TACROLIMUS. Patient died on 03/11/2007.Busulfex Side Effects Report #5886252-X
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Sept 01, 2008. Male patient, 67 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, chest discomfort, constipation
, convulsion, diarrhoea, encephalitis viral, erythema, malaise, oedema. Busulfex dosage: 30 ML INTRAVENOUS. During the same period patient was treated with MELPHALAN, TACROLIMUS. Patient died.Busulfex Side Effects Report #5819582-8
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 07, 2008. Male patient, 66 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, cystitis, cytomegalovirus enterocolitis, diarrhoea, graft versus host disease, interstitial lung disease, malaise, nausea
. Busulfex dosage: 25.5 ML; INTRAVENOUS, 34 ML, DAILY DOSE; INTRAVENOUS, 8.5 ML, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with CYTARABINE, FLUDARABINE PHOSPHATE, MELPHALAN, VALPROATE, FILGRASTIM, TACROLIMIS. Patient died.Busulfex Side Effects Report #5874064-2
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 19, 2008. Male patient, 66 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, acute myeloid leukaemia recurrent, blood bilirubin increased, cystitis, cytomegalovirus enterocolitis, interstitial lung disease, malaise, staphylococcal sepsis, stomatitis. Busulfex dosage: 25.5 ML, INTRAVENOUS; 34 ML, DAILY DOSE; INTRAVENOUS; 8.5 ML, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with CYTARABINE, FLUDARABINE PHOSPHATE, MELPHALAN, VALPROATE, FILGRASTIM, TACROLIMUS. Patient died.
Busulfex Side Effects Report #5818262-2
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 07, 2008. Male patient, 64 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: cystitis, diarrhoea, encephalitis viral, malaise, nausea
, pneumonia , streptococcal sepsis. Busulfex dosage: 19.5 ML, DAILY DOSE INTRAVENOUS; 26 ML, DAILY DOSE; INTRAVENOUS; 6.5 ML, DAILY DOSE; INTRAVENOU. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, FILGRASTIM, TACROLIMUS, MYCOPHENOLATE MOFETIL. Patient recovered.Busulfex Side Effects Report #6053557-1
Busulfex side effect was reported by a Health Professional from JAPAN on Jan 14, 2009. Female patient, 64 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, anorexia, bone marrow transplant rejection, chronic graft versus host disease, diarrhoea, febrile neutropenia, gamma-glutamyltransferase increased, malaise, nausea
. Busulfex dosage: 4.8 ML, TID; 4.8 ML, QID; 4.8 ML, QD. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYTARABINE, PHENYTOIN, DEPAKENE, LENOGRASTIM, TACROLIMUS. Patient recovered.Busulfex Side Effects Report #5786817-X
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on June 09, 2008. Male patient, 63 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, diarrhoea, graft versus host disease, headache
, malaise, nausea , oedema, pain in extremity, pneumonia . Busulfex dosage: 30 ML. During the same period patient was treated with MELPHALAN, TACROLIMUS. Patient died.Busulfex Side Effects Report #5878607-4
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 25, 2008. Male patient, 63 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, diarrhoea, graft versus host disease, headache
, malaise, nausea , oedema, pain in extremity, pneumonia . Busulfex dosage: 30 ML, DAILY DOSE INTRAVENOUS. During the same period patient was treated with MELPHALAN, TACROLIMUS. Patient died.Busulfex Side Effects Report #5972679-4
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Nov 13, 2008. Male patient, 63 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, diarrhoea, graft versus host disease, headache
, malaise, nausea , oedema, pain in extremity, pneumonia . Busulfex dosage: 30 ML, DAILY DOSE. During the same period patient was treated with MELPHALAN, TACROLIMUS. Patient died on 10/16/2007.Busulfex Side Effects Report #5819491-4
Busulfex side effect was reported by a Health Professional from JAPAN on July 08, 2008. Male patient, 62 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, diarrhoea, enterococcal sepsis, malaise, nausea
, stomatitis, treatment failure. Busulfex dosage: 30 ML, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, MELPHALAN, FILGRASTIM, TACROLIMUS, MYCOPHENOLATE MOFETIL. Patient recovered.Busulfex Side Effects Report #5877275-5
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 27, 2008. Male patient, 62 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, diarrhoea, enterococcal sepsis, leukaemia recurrent, malaise, nausea
, stomatitis. Busulfex dosage: 30 ML, UNK, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, MELPHALAN, FILGRASTIM, TACROLIMUS, MYCOPHENOLATE MOFETIL. Patient died on 05/15/2007.Busulfex Side Effects Report #5839357-3
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 30, 2008. Male patient, 60 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia recurrent, diarrhoea, malaise, stomatitis. Busulfex dosage: 192 ML, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, FILGRASTIM, METHOTREXATE, TACROLIMUS. Patient recovered.
Busulfex Side Effects Report #5822822-2
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 14, 2008. Female patient, child 6 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, febrile neutropenia, malaise, stomatitis. Busulfex dosage: 72 MG INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, MELPHALAN, PHENYTOIN, FILGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient recovered.
Busulfex Side Effects Report #5849536-7
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 08, 2008. Female patient, 59 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, acute myeloid leukaemia recurrent, anorexia, cytomegalovirus viraemia, diarrhoea, hypocalcaemia, malaise, platelet count decreased, renal failure acute. Busulfex dosage: 14 ML, DAILY DOSE INTRAVENOUS; 28 ML, DAILY DOSE; INTRAVENOUS; DAILY DOSE; INTRAVENOUS. During the same period patient was treated with PHENYTOIN, MELPHALAN, CYCLOSPORINE. Patient was hospitalized. Patient died on 09/07/2007.
Busulfex Side Effects Report #5894817-4
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Sept 11, 2008. Male patient, 59 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, aspergillosis, cytomegalovirus viraemia, diarrhoea, interstitial lung disease, malaise, nausea
, oropharyngeal pain, pruritus. Busulfex dosage: 184 MG, DAILY DOSE INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYTARABINE, CYCLOSPORINE, MYCOPHENOLATE MOFETIL, FILGRASTIM. Patient died on 10/28/2007.Busulfex Side Effects Report #5729836-1
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Apr 21, 2008. Male patient, 58 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, bone marrow transplant
, cerebral haemorrhage, diarrhoea, malaise, multi-organ failure, pneumonia , sepsis , shock. Busulfex dosage: 33.2 ML INTRAVENOUS; 16.6 ML INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, MELPHALAN, VALPROATE, METHOTREXATE. Patient was hospitalized. Patient died.Busulfex Side Effects Report #5798835-6
Busulfex side effect was reported by a Health Professional from JAPAN on June 16, 2008. Male patient, 58 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia recurrent, anorexia, enterocolitis, febrile neutropenia, graft versus host disease, malaise, nausea
, stomatitis. Busulfex dosage: 460 MG INTRAVENOUS. During the same period patient was treated with PHENYTOIN, NEUPOGEN, MITOXANTRONE HYDROCHLORIDE, METHOTREXATE, CYCLOSPORINE, MITOXANTRONE HYDROCHLORIDE. Patient died.Busulfex Side Effects Report #5809438-9
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on June 27, 2008. Male patient, 58 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, cytomegalovirus colitis, diarrhoea, febrile neutropenia, malaise, nausea
. Busulfex dosage: 15.2 ML, DAILY DOSE, INTRAVENOUS; 20 ML, DAILY DOSE; INTRAVENOUS; 40 ML; DAILY DOSE; INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VALPROATE, NARTOGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5989584-X
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Nov 21, 2008. Male patient, 58 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, anorexia, cytomegalovirus colitis, diarrhoea, febrile neutropenia, malaise, nausea
, stem cell transplant. Busulfex dosage: 15.2 ML, DAILY DOSE. During the same period patient was treated with PREDNISOLONE, CYCLOPHOSPHAMIDE, VALPROATE, NARTOGRASTIM, CYCLOSPORINE. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5990196-2
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Dec 01, 2008. Male patient, 58 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia recurrent, anorexia, diarrhoea, enterocolitis viral, febrile neutropenia, graft versus host disease, malaise, nausea
, stomatitis. Busulfex dosage: 460 MG. During the same period patient was treated with METHOTREXATE, MITOXANTRONE HYDROCHLORIDE, FLUDARABINE PHOSPHATE, PHENYTOIN, FILGRASTIM, CYCLOSPORINE. Patient died.Busulfex Side Effects Report #6060141-2
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Jan 15, 2009. Male patient, 58 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia recurrent, anorexia, enterocolitis viral, febrile neutropenia, graft versus host disease, malaise, nausea
, stomatitis. Busulfex dosage: 460 MG, INTRAVENOUS. During the same period patient was treated with METHOTREXATE, CYCLOSPORINE, MITOXANTRONE HYDROCHLORIDE, FLUDARABINE PHOSPHATE, PHENYTOIN, FILGRASTIM. Patient died on 11/18/2007.Busulfex Side Effects Report #5782929-5
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on June 11, 2008. Female patient, 57 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, bone marrow transplant
, malaise, nausea , sepsis . Busulfex dosage: 30 ML, INTRAVENOUS. During the same period patient was treated with MELPHALAN. Patient died on 07/19/2006.Busulfex Side Effects Report #5872400-4
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 20, 2008. Female patient, 57 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia recurrent, anorexia, bone marrow transplant
, diarrhoea, febrile neutropenia, malaise, nausea , reticulocyte count decreased, stomatitis. Busulfex dosage: 30 ML, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, LENOGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient died.Busulfex Side Effects Report #5893736-7
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Sept 04, 2008. Female patient, 57 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, bacterial sepsis, malaise, pseudomonal sepsis, septic shock, stomatitis. Busulfex dosage: 12.8 MG/KG, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, FILGRASTIM. Patient died.
Busulfex Side Effects Report #5912041-3
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Sept 25, 2008. Male patient, 57 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: enterococcal sepsis, febrile neutropenia, haemorrhoids, malaise, malignant neoplasm progression, pruritus, rash
, stomatitis. Busulfex dosage: 14.8 ML, DAILY DOSE INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, FILGRASTIM, LENOGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient recovered.Busulfex Side Effects Report #5877535-8
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 26, 2008. Female patient, 55 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, blood potassium decreased, blood sodium decreased, bone marrow transplant rejection, malaise, nausea
, transplant failure. Busulfex dosage: 192 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, PHENYTOIN, FILGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient recovered.Busulfex Side Effects Report #5877537-1
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 25, 2008. Male patient, 55 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, adenoviral haemorrhagic cystitis, constipation
, diabetes insipidus , dyspnoea, malaise, nausea , pyrexia, stomatitis. Busulfex dosage: 30 ML, DAILY DOSE INTRAVENOUS. During the same period patient was treated with ANTITHYMOCYTE IMMUNOGLOBULIN, MELPHALAN, TACROLIMUS. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5965383-X
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Nov 10, 2008. Male patient, 55 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, asthma
, constipation , cystitis haemorrhagic, diabetes insipidus , dyspnoea, malaise, myocarditis, nausea . Busulfex dosage: 30 ML, DAILY DOSE , INTRAVENOUS. During the same period patient was treated with THYMOGLOBULIN, MELPHALAN, TACROLIMUS. Patient was hospitalized. Patient died.Busulfex Side Effects Report #6026260-1
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Dec 18, 2008. Male patient, 55 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, adenoviral haemorrhagic cystitis, asthma
, constipation , diabetes insipidus , malaise, myocarditis, nausea , stomatitis. Busulfex dosage: 30 ML, DAILY DOSE. During the same period patient was treated with ANTITHYMOCYTE IMMUNOGLOBULIM, MELPHALAN, TACROLIMUS. Patient was hospitalized. Patient died on 05/29/2008.Busulfex Side Effects Report #5729824-5
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Apr 21, 2008. Male patient, 54 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, diarrhoea, localised infection, malaise, staphylococcal infection
, stomatitis. Busulfex dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, PHENYTOIN, LENOGRASTIM, TACROLIMUS HYDRATE. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5809452-3
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on June 23, 2008. Male patient, 53 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, malaise, malignant neoplasm progression, nausea
, pneumonia , staphylococcal sepsis, stem cell transplant, stomatitis. Busulfex dosage: 7.5 ML, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, NEUPOGEN, METHOTREXATE, CYCLOSPORINE. Patient died on 08/15/2007.Busulfex Side Effects Report #5811572-4
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 01, 2008. Male patient, 53 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, malaise, peritonsillitis, stomatitis. Busulfex dosage: 32 ML, DAILY DOSE. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, FILGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient recovered.
Busulfex Side Effects Report #5886250-6
Busulfex side effect was reported by a Health Professional from JAPAN on Sept 01, 2008. Male patient, 53 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, acute myeloid leukaemia recurrent, anorexia, bone marrow transplant
, diarrhoea, headache , malaise, nausea , pain in extremity. Busulfex dosage: 12 ML, INTRAVENOUS; 24 ML, DAILY: INTRAVENOUS; DAILY DOSE; INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, PHENYTOIN, METHOTREXATE, TACROLIMUS. Patient recovered.Busulfex Side Effects Report #5893733-1
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Sept 05, 2008. Female patient, 53 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, anorexia, diarrhoea, hyperglycaemia, klebsiella sepsis, liver disorder, malaise, nausea
, pneumonia klebsiella. Busulfex dosage: 27.2 ML, INTRAVENOUS. During the same period patient was treated with CYCLOSPORINE, FLUDARABINE PHOSPHATE, VALPROATE, NARTOGRASTIM, METHOTREXATE, METHYLPREDNISOLONE. Patient died.Busulfex Side Effects Report #5989585-1
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Nov 20, 2008. Male patient, 53 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, cytomegalovirus viraemia, diarrhoea, febrile neutropenia, hepatic function abnormal, hyperkalaemia, hyponatraemia, malaise, nausea
. Busulfex dosage: 8 ML, TID. During the same period patient was treated with DEPAKENE, CYCLOPHOSPHAMIDE, NEUTROGIN, METHOTREXATE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5729830-0
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Apr 21, 2008. Female patient, 52 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: adenoviral haemorrhagic cystitis, anorexia, blood potassium decreased, engraft failure, malaise, nausea
, pharyngeal oedema, pneumonia bacterial, pulmonary haemorrhage. Busulfex dosage: 26.8 ML, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYTARABINE, MITOXANTRONE, PHENYTOIN, NEUPOGEN, METHOTREXATE, TACROLIMUS. Patient died.Busulfex Side Effects Report #5984857-9
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Nov 18, 2008. Female patient, 52 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: adult t-cell lymphoma/leukaemia recurrent, anorexia, bone marrow transplant
, cytomegalovirus viraemia, diarrhoea, hypokalaemia, malaise, nausea . Busulfex dosage: 6.4 ML, QD. During the same period patient was treated with DEPAKENE, FLUDARABINE PHOSPHATE, FILGRASTIM. Patient recovered.Busulfex Side Effects Report #5819606-8
Busulfex side effect was reported by a Health Professional from JAPAN on July 08, 2008. Male patient, 51 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, cystitis haemorrhagic, diarrhoea, malaise, malignant neoplasm progression, nausea
, stem cell transplant, stomatitis. Busulfex dosage: 24 ML, DAILY DOSE INTRAVENOUS; 32 ML, DAILY DOSE; INTRAVENOUS; 8 ML, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VALPROATE, FILGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient was hospitalized. Patient died on 08/26/2007.Busulfex Side Effects Report #5888694-5
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Sept 03, 2008. Female patient, 51 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, anorexia, bone marrow transplant rejection, diarrhoea, febrile neutropenia, malaise, malignant neoplasm progression, nausea
. Busulfex dosage: 25.88 ML. During the same period patient was treated with FLUDARABINE PHOSPHATE, MELPHALAN, LENOGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5893732-X
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Sept 05, 2008. Female patient, 51 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, adult t-cell lymphoma/leukaemia recurrent, anorexia, bone marrow transplant
, cytomegalovirus enterocolitis, malaise, stomatitis, vomiting. Busulfex dosage: 24 ML, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VALPROATE, FILGRASTIM, METHOTREXATE, TACROLIMUS. Patient recovered.Busulfex Side Effects Report #5729827-0
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Apr 21, 2008. Male patient, 50 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: abdominal pain
, acute graft versus host disease, cytomegalovirus viraemia, diarrhoea, febrile neutropenia, malaise, rash , stomatitis. Busulfex dosage: 24 ML, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, NEUPOGEN, METHOTREXATE, TACROLIMUS. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5798829-0
Busulfex side effect was reported by a Health Professional from JAPAN on June 16, 2008. Female patient, 50 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, bone marrow transplant
, cytomegalovirus viraemia, enterocolitis, graft versus host disease, malaise, multi-organ failure, myelodysplastic syndrome. Busulfex dosage: 32 ML, INTRAVENOUS; 16 ML, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, MELPHALAN, METHOTREXATE, CYCLOSPORINE. Patient was hospitalized. Patient died.Busulfex Side Effects Report #5883704-3
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 29, 2008. Male patient, 50 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia recurrent, anorexia, diarrhoea, hiccups, malaise, nausea
, neutropenia, oedema, rash . Busulfex dosage: 24.6 ML, INTRAVENOUS; 32.8 ML, DAILY DOSE; INTRAVENOUS; 8.2 ML, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with CYTARABINE, VALPROATE, CYCLOPHOSPHAMIDE, NARTOGRASTIM, METHOTREXATE, TACROLIMUS. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5958872-5
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Nov 04, 2008. Male patient, 50 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia recurrent, anorexia, cytomegalovirus viraemia, diarrhoea, hiccups, malaise, nausea
, neutropenia, oedema. Busulfex dosage: 8.2 ML, TID INTRAVENOUS; 8.2 ML, QID; INTRAVENOUS; 8.2 ML, QD; INTRAVENOUS. During the same period patient was treated with CYTARABINE, VALPROATE, CYCLOPHOSPHAMIDE, NARTOGRASTIM, METHOTREXATE, TACROLIMUS. Patient was hospitalized and became disabled. Patient died.Busulfex Side Effects Report #5819591-9
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 07, 2008. Male patient, 49 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, graft versus host disease, jaundice
, malaise, nausea , stomatitis. Busulfex dosage: 24 ML; 32 ML, DAILY DOSE; INTRAVENOUS; 8 ML, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, FILGRASTIM, CYCLOSPORINE. Patient recovered.Busulfex Side Effects Report #5886249-X
Busulfex side effect was reported by a Health Professional from JAPAN on Sept 03, 2008. Female patient, 48 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, bone marrow transplant rejection, diarrhoea, febrile neutropenia, gastrointestinal haemorrhage, graft versus host disease, malaise, nausea
, renal disorder. Busulfex dosage: 27.72ML INTRAVENOUS. During the same period patient was treated with GANCICLOVIR, FLUDARABINE PHOSPHATE, VALPROATE, LENOGRASTIM, METHOTREXATE, TACROLIMUS. Patient was hospitalized. Patient died.Busulfex Side Effects Report #5819511-7
Busulfex side effect was reported by a Health Professional from JAPAN on July 08, 2008. Female patient, 47 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, bone marrow transplant
, diarrhoea, gastrointestinal haemorrhage, malaise, multi-organ failure, nausea . Busulfex dosage: 6 ML INTRAVENOUS; 24 ML, DAILY DOSE; INTRAVENOUS; 18 ML, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VALPROATE, NARTOGRASTIM, METHOTREXATE, TACROLIMUS. Patient died.Busulfex Side Effects Report #5979847-6
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Nov 18, 2008. Female patient, 47 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, ascites, diarrhoea, gastrointestinal haemorrhage, malaise, multi-organ failure, nausea
. Busulfex dosage: 6 ML, DAILY DOSE, INTRAVENOUS; 6 ML, QID, INTRAVENOUS; 6 ML, TID, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VALPROATE, NARTOGRASTIM, METHOTREXATE, TACROLIMUS. Patient died.Busulfex Side Effects Report #6076410-6
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Jan 27, 2009. Female patient, 47 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, ascites, diarrhoea, gastrointestinal haemorrhage, malaise, multi-organ failure, nausea
. Busulfex dosage: 6 ML, DAILY DOSE INTRAVENOUS ; 6 ML, QID, INTRAVENOUS ; 6 ML, TID, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VALPROATE, NARTOGRASTIM, METHOTREXATE, TACROLIMUS. Patient died on 07/03/2007.Busulfex Side Effects Report #5822823-4
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 14, 2008. Male patient, 46 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia recurrent, anorexia, convulsion, diarrhoea, graft versus host disease, malaise, nausea
, staphylococcal sepsis, stomatitis. Busulfex dosage: 27 ML, INTRAVENOUS, 36 ML DAILY DOSE; INTRAVENOUS, 9 ML, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, LENOGRASTIM, TACROLIMUS, CYTARABINE. Patient was hospitalized. Patient died on 08/29/2007.Busulfex Side Effects Report #5862345-8
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 12, 2008. Male patient, 46 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, anorexia, diarrhoea, enterocolitis, hyponatraemia, malaise, nausea
, renal failure acute, stomatitis. Busulfex dosage: 40 ML. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, METHOTREXATE, TACROLIMUS. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5920081-3
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Sept 30, 2008. Male patient, 46 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, bone marrow transplant rejection, cytomegalovirus infection
, gastrointestinal ulcer, gastrointestinal ulcer haemorrhage, liver function test abnormal, malaise, nausea , stem cell transplant. Busulfex dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, ETOPOSIDE, PHENYTOIN, FILGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient died on 12/08/2006.Busulfex Side Effects Report #5798834-4
Busulfex side effect was reported by a Health Professional from JAPAN on June 16, 2008. Female patient, 45 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, leukaemia recurrent, leukocytosis, malaise, nausea
, oral disorder. Busulfex dosage: 5.3 ML INTRAVENOUS; 21.2 ML, DAILY DOSE; INTRAVENOUS; 15.9 ML, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VALPROATE, NEUPOGEN, METHOTREXATE, TACROLIMUS. Patient died on 04/14/2007.Busulfex Side Effects Report #5800910-4
Busulfex side effect was reported by a Physician from JAPAN on June 19, 2008. Male patient, 44 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, diarrhoea, encephalitis viral, malaise, septic shock. Busulfex dosage: 5 ML, TID, INTRAVENOUS; 8.5 ML, QID; INTRAVENOUS; 8.5 ML, SINGLE; INTRAVENOUS. During the same period patient was treated with NARTOGRASTIM, TACROLIMUS, PHENYTOIN, CYCLOPHOSPHAMIDE. Patient died on 01/28/2007.
Busulfex Side Effects Report #5878609-8
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 25, 2008. Female patient, 44 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, constipation
, diarrhoea, encephalitis viral, jaundice , malaise, nausea , oropharyngeal pain, pruritus. Busulfex dosage: 26.8 ML, DAILY DOSE INTRAVENOUS. During the same period patient was treated with MELPHALAN, TACROLIMUS. Patient died.Busulfex Side Effects Report #5979833-6
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Nov 13, 2008. Female patient, 44 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: abdominal discomfort, anorexia, constipation
, diarrhoea, encephalitis herpes, jaundice , malaise, nausea , oropharyngeal pain. Busulfex dosage: 26.8 ML, DAILY DOSE, INTRAVENOUS. During the same period patient was treated with MELPHALAN, TACROLIMUS. Patient died on 11/10/2007.Busulfex Side Effects Report #5979835-X
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Nov 12, 2008. Female patient, 44 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, blood urea increased, jaundice
, malaise, sepsis , stomatitis. Busulfex dosage: 30 MG, QID, INTRAVENOUS. During the same period patient was treated with DEPAKENE, CYCLOPHOSPHAMIDE, METHOTREXATE, TACROLIMUS, METHYLPREDNISOLONE, CELLCEPT USA. Patient died on 07/16/2007.Busulfex Side Effects Report #5729835-X
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Apr 21, 2008. Female patient, 43 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, anorexia, diarrhoea, febrile neutropenia, malaise, meningitis
, stem cell transplant. Busulfex dosage: 28.28 ML INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, MELPHALAN, VALPROATE, CYCLOSPORINE, IRINOTECAN. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5878610-4
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 26, 2008. Male patient, 43 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, acute myeloid leukaemia recurrent, anorexia, diarrhoea, haemodialysis, hepatic function abnormal, malaise, meningitis viral. Busulfex dosage: 36 ML, INTRAVENOUS. During the same period patient was treated with LENOGRASTIM, FILGRASTIM, FLUDARABINE PHOSPHATE, VALPROATE, TACROLIMUS. Patient died.
Busulfex Side Effects Report #6016154-X
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Dec 09, 2008. Female patient, 43 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, anorexia, chronic graft versus host disease, diarrhoea, hyponatraemia, malaise, pharyngitis, stomatitis. Busulfex dosage: 22 ML INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VALPROATE, FILGRASTIM, METHOTREXATE. Patient died on 08/31/2008.
Busulfex Side Effects Report #5831998-2
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 22, 2008. Male patient, 42 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, diarrhoea, malaise, malignant neoplasm progression, phlebitis, stomatitis. Busulfex dosage: 24 ML, DAILY DOSE; 32 ML, DAILY DOSE. During the same period patient was treated with CYCLOPHOSPHAMIDE, VALPROATE, FILGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient recovered.
Busulfex Side Effects Report #5839352-4
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 28, 2008. Male patient, 42 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, bone marrow transplant rejection, cytomegalovirus viraemia, diarrhoea, folliculitis, hepatic function abnormal, hyperamylasaemia, malaise, staphylococcal bacteraemia. Busulfex dosage: 20 ML, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, NARTOGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient recovered.
Busulfex Side Effects Report #5921366-7
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Oct 01, 2008. Female patient, 41 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, cytomegalovirus antibody positive, malaise, nausea
, pneumonia cytomegaloviral, respiratory failure, stomatitis. Busulfex dosage: 3.2 MG, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYTARABINE, CYCLOSPORINE, CELLCEPT USA, NEUTROGIN. Patient died.Busulfex Side Effects Report #6060138-2
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Jan 16, 2009. Female patient, 41 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, blood potassium decreased, blood potassium increased, cytomegalovirus antigen positive, disseminated intravascular coagulation, malaise, nausea
, pneumonia cytomegaloviral, respiratory failure. Busulfex dosage: 3.2 MG, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYTARABINE, CYCLOSPORINE, CELLCEPT USA, NEUTROGIN. Patient was hospitalized. Patient died on 06/30/2007.Busulfex Side Effects Report #5698170-0
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Mar 21, 2008. Female patient, 40 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acinetobacter infection, acute graft versus host disease, anorexia, cystitis haemorrhagic, cytomegalovirus antigen positive, liver disorder, malaise, mucous membrane disorder, nausea
. Busulfex dosage: 31.2 ML, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, METHOTREXATE, ITRACONAZOLE, GANCICLOVIR. Patient was hospitalized and became disabled. Patient recovered.Busulfex Side Effects Report #5900854-3
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Sept 16, 2008. Male patient, child 4 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: blood potassium decreased, bone marrow transplant rejection, dysphagia, haemodialysis, hepatic cirrhosis, malaise, mucosal erosion, stomatitis, venoocclusive liver disease. Busulfex dosage: 8.1 ML; 10.8 ML, DAILY DOSE; INTRAVENOUS; 2.7 ML, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with MELPHALAN, PHENYTOIN, FILGASTRIM. Patient was hospitalized. Patient recovered.
Busulfex Side Effects Report #5819595-6
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 07, 2008. Female patient, 36 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, bacterial sepsis, diarrhoea, enterobacter sepsis, malaise, nausea
, pneumonia viral, stomatitis. Busulfex dosage: 165 ML, DAILY DOSE; 220 ML, DAILY DOSE; INTRAVENOUS; 55 ML, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, MELPHALAN, FILGRASTIM, TACROLIMUS. Patient died.Busulfex Side Effects Report #6015344-X
Busulfex side effect was reported by a Health Professional from JAPAN on Dec 09, 2008. Male patient, 34 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, bone marrow transplant rejection, malaise, nausea
, pharyngitis. Busulfex dosage: 6.67 ML QID. During the same period patient was treated with ENDOXAN NET, DEPAKENE, FILGRASTIM, METHOTREXATE, TACROLIMUS. Patient recovered.Busulfex Side Effects Report #5772098-X
Busulfex side effect was reported by a Physician from JAPAN on June 02, 2008. Female patient, 33 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, ascites, blood bilirubin increased, dehydration, diarrhoea, hepatic function abnormal, malaise, multi-organ failure, nausea
. Busulfex dosage: 147.2 ML, INTRAVENOUS. Patient died.Busulfex Side Effects Report #5947667-4
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Oct 29, 2007. Male patient, 33 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, bone marrow transplant rejection, diarrhoea, malaise, nausea
, pneumonia staphylococcal, staphylococcal infection , stenotrophomonas sepsis, stomatitis. Busulfex dosage: 6 ML, QID, INTRAVENOUS. During the same period patient was treated with VALPROATE, FLUDARABINE PHOSPHATE, LENOGRASTIM, METHOTREXATE, TACROLIMUS. Patient was hospitalized. Patient died on 04/22/2007.Busulfex Side Effects Report #5809436-5
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on June 27, 2008. Female patient, 32 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, anorexia, cystitis haemorrhagic, cytomegalovirus viraemia, diabetes mellitus, diarrhoea, escherichia sepsis, malaise, nausea
. Busulfex dosage: 22.5 ML, INTRAVENOUS; 9 ML; INTRAVENOUS; 36 ML, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VALPROATE, NEUPOGEN, METHOTREXATE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5886251-8
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 29, 2008. Male patient, child 3 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, anorexia, diarrhoea, malaise, neuroblastoma recurrent, stomatitis. Busulfex dosage: 10.4 ML, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, LENOGRASTIME, METHOTREXATE, TACROLIMUS. Patient recovered.
Busulfex Side Effects Report #5849781-0
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 08, 2008. Female patient, 29 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, acute myeloid leukaemia recurrent, anorexia, diarrhoea, malaise, pharyngitis, stomatitis. Busulfex dosage: 11 ML, INTRAVENOUS, 22 ML, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, PHENYTOIN, FILGRASTIM, METHOTREXATE, TACROLIMUS. Patient recovered.
Busulfex Side Effects Report #5819490-2
Busulfex side effect was reported by a Health Professional from JAPAN on July 08, 2008. Female patient, 28 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, anorexia, condition aggravated, diarrhoea, febrile neutropenia, malaise, nausea
, stomatitis. Busulfex dosage: 21.6 ML, INTRAVENOUS; 28.8 ML, DAILY DOSE; INTRAVENOUS; 7.2 ML, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, PHENYTOIN, FILGRASTIM, CYCLOSPORINE, MYCOPHENOLATE MOFETIL. Patient died on 09/02/2007.Busulfex Side Effects Report #5834903-8
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 24, 2008. Female patient, 22 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, anorexia, diarrhoea, encephalitis viral, gamma-glutamyltransferase increased, malaise, nausea
, pigmentation disorder, stomatitis. Busulfex dosage: 15 ML, INTRAVENOUS; 20 ML, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, MELPHALAN, VALPROATE, LENOGRASTIM, TACROLIMUS, SULFAMETHOXAZOLETRIMETHOPRIM. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5743652-6
Busulfex side effect was reported by a Health Professional from JAPAN on May 08, 2008. Male patient, 20 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, gamma-glutamyltransferase increased, malaise, nausea
. Busulfex dosage: 80 MG; 160 MG; 160 MG. During the same period patient was treated with MELPHALAN, PHENYTOIN, LENOGRASTIM. Patient was hospitalized and became disabled. Patient recovered.Busulfex Side Effects Report #5972682-4
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Nov 12, 2008. Male patient, 20 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, blood bilirubin increased, blood potassium decreased, gamma-glutamyltransferase increased, malaise, nausea
, stem cell transplant. Busulfex dosage: 40 MG, BID. During the same period patient was treated with MELPHALAN, PHENYTOIN, LENOGRASTIM. Patient was hospitalized and became disabled. Patient recovered.Busulfex Side Effects Report #5800895-0
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on June 20, 2008. Female patient, child 2 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, enterococcal sepsis, malaise, nausea
, stomatitis. Busulfex dosage: 10 ML, DAILY DOSE. During the same period patient was treated with MELPHALAN, CLONAZEPAM, NEUPOGEN, METHOTREXATE, CYCLOSPORINE. Patient recovered.Busulfex Side Effects Report #5869635-3
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 18, 2008. Female patient, child 2 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, enterococcal sepsis, malaise, nausea
, platelet count decreased, stomatitis. Busulfex dosage: 10 ML, DAILY DOSE INTRAVENOUS. During the same period patient was treated with GEMTUZUMAB, MELPHALAN, CLONAZEPAM, FILGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient recovered.Busulfex Side Effects Report #5877273-1
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 26, 2008. Female patient, child 2 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, acute myeloid leukaemia recurrent, anorexia, bone marrow transplant
, herpes virus infection, liver disorder, malaise, nausea . Busulfex dosage: 9.6 ML, UNK, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VALPROATE, LENOGRASTIM, NARTOGRASTIM, METHOTREXATE. Patient died on 10/07/2007.Busulfex Side Effects Report #5769155-0
Busulfex side effect was reported by a Health Professional from JAPAN on May 29, 2008. Female patient, 18 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, diarrhoea, malaise, nausea
. Busulfex dosage: 13.2 ML, INTRAVENOUS. During the same period patient was treated with AMRUBICIN HYDROCHLORIDE, FLUDARABINE PHOSPHATE, VALPROATE, LENOGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient recovered.Busulfex Side Effects Report #5811550-5
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 01, 2008. Female patient, 18 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, diarrhoea, malaise, sepsis
, stem cell transplant, stomatitis, thrombotic microangiopathy, venoocclusive liver disease. Busulfex dosage: 13 ML, DAILY DOSE; 26 ML, DAILY DOSE. During the same period patient was treated with VALPROATE, MELPHALAN, FILGRASTIM, CYCLOSPORINE. Patient recovered.Busulfex Side Effects Report #5782932-5
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on June 11, 2008. Male patient, 17 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, bone marrow transplant
, diarrhoea, malaise, nausea , sepsis , stomatitis. Busulfex dosage: 40 ML, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, LENOGRASTIM, METHOTREXATE, TACROLIMUS. Patient recovered.Busulfex Side Effects Report #5900850-6
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Sept 16, 2008. Male patient, 17 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: bilirubin conjugated increased, blast cells present, hyperbilirubinaemia, jaundice
, leukaemia recurrent, malaise, malignant neoplasm progression, venoocclusive liver disease. Busulfex dosage: 144 MG. During the same period patient was treated with CYTARABINE, PHENYTOIN. Patient died on 04/03/2007.Busulfex Side Effects Report #5803066-7
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on June 23, 2008. Male patient, 16 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, blood lactate dehydrogenase increased, diarrhoea, hepatic enzyme increased, malaise, nausea
, sepsis . Busulfex dosage: 20.1 ML; INTRAVENOUS; 26.8 ML, DAILY DOSE; INTRAVENOUS; 6.7 ML, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, PHENYTOIN, NEUPOGEN, METHOTREXATE, TACROLIMUS. Patient recovered.Busulfex Side Effects Report #5819596-8
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 08, 2008. Female patient, 13 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, blood albumin decreased, cystitis haemorrhagic, diarrhoea, dysphagia, graft versus host disease, hepatic enzyme increased, malaise, nausea
. Busulfex dosage: 21.92 ML, INTRAVENOUS. During the same period patient was treated with MELPHALAN, VALPROATE, FILGRASTIM, LENOGRASTIM, CYCLOSPORINE, TACROLIMUS, METHYLPREDNISOLONE. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5822815-5
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 14, 2008. Female patient, 13 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, bone marrow transplant
, febrile neutropenia, malaise, stomatitis, transplant rejection. Busulfex dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, ANTILYMPHOCYTE IMMUNOGLOBULIN, PHENYTOIN, FILGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient recovered.Busulfex Side Effects Report #5900852-X
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Sept 16, 2008. Female patient, 13 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute lymphocytic leukaemia recurrent, anorexia, bone marrow transplant
, bone marrow transplant rejection, febrile neutropenia, gamma-glutamyltransferase increased, hypokalaemia, malaise, pyrexia. Busulfex dosage: 58 MG. During the same period patient was treated with CYCLOPHOSPHAMIDE, ANTILYMPHOCYTE IMMUNOGOLBULIN, PHENYTOIN, FILGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient recovered.Busulfex Side Effects Report #5819420-3
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 08, 2008. Female patient, child 12 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, cellulitis
, malaise, nail infection, nausea , pseudomonas infection, staphylococcal sepsis, stomatitis. Busulfex dosage: 14.1 ML, INTRAVENOUS; 18.8 ML, DAILY DOSE; INTRAVENOUS; 4.7 ML, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with ETOPOSIDE, FLUDARABINE PHOSPHATE, VALPROATE, LENOGRASTIM, METHOTREXATE, TACROLIMUS. Patient recovered.Busulfex Side Effects Report #5819425-2
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 08, 2008. Female patient, child 12 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, diarrhoea, dry mouth, epistaxis, haematuria, malaise, nausea
, staphylococcal sepsis, stem cell transplant. Busulfex dosage: 18 ML, INTRAVENOUS. During the same period patient was treated with THIOTEPA, MELPHALAN, PHENYTOIN, LENOGRASTIM. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5878642-6
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 26, 2008. Female patient, child 12 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, anorexia, bone marrow transplant
, clostridial infection, diarrhoea, malaise, nausea , rhabdomyosarcoma recurrent, stomatitis. Busulfex dosage: 9 ML, DAILY DOSE INTRAVENOUS; 18 ML, DAILY DOSE; INTRAVENOUS; DF, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with MELPHALAN, PHENYTOIN, FILGRASTIM, CYCLOSPORINE, METHYLPREDNISOLONE. Patient recovered.Busulfex Side Effects Report #5893534-4
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Sept 08, 2008. Female patient, child 12 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: bone marrow transplant rejection, diarrhoea, dry mouth, epistaxis, haematuria, malaise, mucous membrane disorder, nausea
, staphylococcal sepsis. Busulfex dosage: 18 ML, INTRAVENOUS. During the same period patient was treated with THIOTEPA, MELPHALAN, PHENYTOIN, LENOGRASTIM. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5979834-8
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Nov 14, 2008. Female patient, child 12 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute lymphocytic leukaemia recurrent, anorexia, cellulitis
, hepatic function abnormal, hypokalaemia, malaise, nail infection, nausea , staphylococcal sepsis. Busulfex dosage: 4.7 ML, TID, INTRAVENOUS, 4.7 ML, QID; INTRAVENOUS, 4.7 ML, QID; INTRAVENOUS. During the same period patient was treated with ETOPOSIDE, FLUDARABINE PHOSPHATE, VALPROATE, LENOGRASTIM, METHOTREXATE, TACROLUMIS. Patient recovered.Busulfex Side Effects Report #6065366-8
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Jan 19, 2009. Female patient, child 12 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, bone marrow transplant rejection, diarrhoea, dry mouth, epistaxis, haematuria, malaise, mucous membrane disorder, nausea
. Busulfex dosage: 18 ML, INTRAVENOUS. During the same period patient was treated with THIOTEPA, MELPHALAN, PHENYTOIN, LENOGRASTIM. Patient was hospitalized. Patient recovered.